chevron_leftBack
As of 24 April 2025, Inspire Medical Systems, Inc. has a market cap of $4.42B USD, ranking #3116 globally and #995 in the United States. It ranks #270 in the Healthcare sector, and #33 in the Medical Devices industry.
Key Stats
Market Cap
$4.42BUSD
Enterprise Value
$4.0BUSD
Revenue (TTM)
$802.8MUSD
EBITDA (TTM)
$42.63MUSD
Net Income (TTM)
$53.51MUSD
EBITDA Margin
5.3%
Profit Margin
6.7%
PE Ratio
84.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Timothy Herbert
open_in_new
Employees
1,246
Founded
2007
IPO
03 May 2018
Website
inspiresleep.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.1% | 1.1% | -9.9% | -21% | -25% | -34% |
Upcoming Earnings
Earnings Date
Mon, May 5
Earnings Time
bedtime
After Close
EPS Estimate
-$0.2300
Revenue Estimate
$194.91M
19% yoy
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
INSP
Inspire Medical Systems Inc
ISIN: US4577301090
Shares Out.:
Shares Outstanding:
29.76M1
Shares Float:
28.317M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
148.57 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
